PLASMA SUBSTITUTES 



83 



65. Kabat, E. a., and D. Berg. Production of precipitins 84. 

 and cutaneous sensitivity in man by injection of small 

 amounts of dextran. Ann. New York Acad. Sc. 55: 471-477, 



1952- 



66. Langdell, R. D., E. .\delson, F. W. Furth, and \V. H. 85. 

 Crosby. Dextran and prolonged bleeding time. Results 



of a sixty-gram one-liter infusion given to one hundred 

 si.xty-three normal human subjects. J. A.M. A. 166: 346, 

 1958. 86. 



67. Leusen, I. R., AND H. E. Essex. Leukopenia and changes 

 in differential leucocyte counts produced in rabbits by 

 dextran and acacia. Am. J. Physiol. 172: 231-236, 1953. 87. 



68. Loeffler, R. K., and J. Scudder. Excretion and distribu- 

 tion of polyvinylpyrrolidone in man as determined by 



use of radiocarbon as a tracer. Am. J. Clin. Path. 23: 88. 



311-321, 1953. 



69. Marshall, L. H., C H. Hanna, H. .Specht, and P. A. 

 Neal. Blood changes of normal dogs during chronic 



blood volume expansion with dextran. Proc. .Soc. Exper. 89. 



Biol. & Med. "]()■. 363-366, 1952. 



70. Maurer, p. H. The antigenicity of polyvinylpyrrolidone. 



J. Immunol, yj : 105, 1956. 90. 



71. Maurer, P. H. Dextran, an antigen in man. Proc. Soc. 

 Exper. Biol. & Med. 83: 879-884, 1953. 



72. Maurer, P. H., and H. Lebovitz. Studies on the anti- 91. 

 genicity of modified fluid gelatin. J. Immunol. 76: 335-341, 



1956. 



73. McClure, R. D., K. VV. Warren, and L. S. Fallis. 92. 

 Intravenous pectin solution in the prophylaxis and 

 treatment of shock. Canad. M.A.J. 51 : 206, 1944. 



74. Metcalf, W., and L. M. Rousselot. Some physiologic 93. 

 effects following dextran infusion in normal subjects. 



Surg. Forum 1952, 5:428-433. 



75. Meyer, L. M., N. I. Berlin, G. M. Hyde, R. J. Parsons, 94. 

 AND B. Whittington. Changes in blood volume following 

 administration of dextran — determined by P'^ labeled 



red cells. Surg. Gynec. & Obst. 94: 712-714, 1952. 95. 



76. Michie, a. J., AND M. C. Ragni. Effect of repeated infu- 

 sions of dextran on renal function. J. Appl. Physiol. 5; 

 625-627, 1952-53. 



77. MicHiE, A. J., C. E. Koop, VV. S. Blakemore, and M. C. 96. 

 Ragni. Effect of modified fluid gelatin on renal function. 



J. Appl. Physiol. 5: 621-624, ■952~53- 



78. Morrison, A. E., J. S. Lundy, and H. E. Essex. An 97. 

 evaluation of replacement fluids in laboratory animals 

 following control hemorrhage. Circulation 5 : 208-2 1 4, 1 952. 



79. Movvry, R. W., and R. C. Millican. A histochemical 98. 

 study of the distribution and fate of dextran in tissues of 



the mouse. Am. J. Path. 29: 523-545, 1953. 



80. MowRY, R. W., J. B. Lonoley, and R. C. Millican. 99. 

 Histochemical demonstration of intravenously injected 

 de.xtran in kidney and liver of the mouse. J. Lab. £? Clin. 



Med. 39: 211-217, 1952. 



81. Nelson, A. A., and L. M. Lusky. Pathological changes in 100. 

 rabbits from repeated intravenous injections of Periston 

 (polyvinylpyrrolidone) or dextran. Proc. Soc. Exper. Biol. 



& Med. 76; 765, 1 95 1. 1 01. 



82. Ohlke, R. F., and J. J. Scales. Plasma augmenters in 

 clinical surgery. Canad. M.A.J. 68: 260-261, 1953. 



83. Padhi, R. K., E. M. Nanson, and R. B. Lynn. Hemo- 102. 

 dynamic changes in graded hemorrhage with special 

 reference to the peripheral circulation. Ann. Surg. 148: 103. 

 827-834, 1958. 



Parkins, \V. M., J. H. Perlmutt, and H. M. Vars. 

 Dextran, oxypolygelatin, and modified fluid gelatin as 

 replacement fluids in experimental hemorrhage. Am. J. 

 Physiol. 173: 403, 1953. 



Popper, H., B. W., Volk, K. A. Me\'er, D. D. Kozoll. 

 AND F. Steigmann. Evaluation of gelatin in pectin solu- 

 tions as substitutes for plasma in the treatment of shock. 

 A..\I.A. Arch. Surg. 50: 34, 1945. 



R.Msz, L. G. Dextran and oxypolygelatin as plasma 

 volume expanders: renal excretion and effects on renal 

 function. J. Lab. & Clin. Med. 40: 880, 1952. 

 Ravin, H. A., A. M. Seligman. and J. Fine. Polyvinyl- 

 pyrrolidone as a plasma expander. New England J. Med. 



^47:921-929. 1952. 



Reinhold, J. G., C. A. J. Von Frijtag Drabbe, M 



Newton, and J. Thomas. Effects of dextran and of 



polyvinylpyrrolidone administration on liver function in 



man. A.AI.A. Arch. Surg. 65: 706-713, 1952. 



Roche, P., R. .\. Dodelin, and VV. L. Bloom. Effect of 



dextran on blood typing and crossmatching. Blood 7 : 



373-375. ■952- 



RooME, N. W., L. Ruttle, L. Williams, and W. Smith. 

 The polyvinyl alcohols as blood substitutes. Canad. 

 M.A.J. 51: 293-299, 1944. 



Scott, R., and J. M. Howard. Hepatic function following 

 wounding and resuscitation with plasma expanders. 

 Ann. Surg. 141 : 357-365, 1955. 



Seegers, W. H., VV. G. Levine, and S. .\. Johnson. 

 Inhibition of prothrombin activation with dextran. 

 J. Appl. Physiol. 7: 617-620, 1954-55. 



Semple, R. E. Changes in protein fractions of dog plasma 

 after bleeding and de.xtran infusion. J. Lab. & Clin. Med. 

 45:61-65, 1955. 



Squire, J. R., J. P. Ball, W. d'A. Maycock, and C. R. 

 RlCKETTs. Dextran. Its Properties and Uses in Medicine. 

 .Springfield, 111.: Thomas, 1955, 91 pp. 

 Stamler, J., L. Dreifus, L. N. Katz, and I. J. Lichton. 

 Response to rapid water, sodium, and dextran loads of 

 intact Ringer's-infused unanesthetized dogs. Am. J. 

 Physiol. 195:362-367, 1958. 



State, D., F. T. Romero, M. Castellanos, and O. H. 

 Wangensteen. Clinical evaluation of bovine serum 

 albumin as a blood substitute. Surgery 22: 424-441, 1947. 

 Steel, R., D. D. Van Sl\-ke, and J. Plazin. The fate of 

 intravenously administered polyvinylpyrrolidone. Ann. 

 New York Acad. Sc. 55: 479-484, 1952. 

 Stern, K. Effect of polyvinylpyrrolidone on reticulo- 

 endothelial storage. Proc. Soc. Exper. Biol. & Med. 79 : 

 618-623, 1952. 



Strumia, M. M., F. W. Chornock, A. D. Blake, and 

 W. G. Karr. The use of a "modified globin" from human 

 erythrocytes as a plasma substitute. Preliminary Report. 

 Am. J. M. Sc. 209: 436-442, 1945. 



Stucki, J. C, and C. R. Thompson. A screening proce- 

 dure for substances which inhibit dextran edema in the 

 rat. Am. J. Physiol. 193: 275, 1958. 



Tarrow, a. B., and E. J. Pulaski. Reactions in man 

 from infusion with dextran. Anesthesiology 14: 359-366, 



1 953' 



Taylor, N. B., and E. T. Waters. Isinglass as a trans- 

 fusion fluid in hemorrhage. Canad. M.A.J. 44 ; 547, 1 941 . 

 Terry, R., C. L. Yuile, A. Golodetz, C. E. Phillips, 

 AND R. R. White. Metabolism of dextran — a plasma 



